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ABSTRACT 
 
Objective: The objective of this selective EBM review is to determine whether or not the 
supplementation of N-3 fatty acids containing DHA throughout pregnancy and 
breastfeeding improve child cognition. 
 
Study Design: Review of three double blind randomized controlled clinical trials (RCTs) 
published in 2003 and 2011. 
 
Data Sources: Three peer-reviewed RCTs were found using PubMed and Medline. These 
studies compared DHA supplementation against various placebos.  
 
Outcomes Measured: enhanced child cognition was assessed via various exams, 
including the Kaufman Assessment Battery for Children (K-ABC) and Fagan tests. 
Significant outcomes were evaluated through the use of SD, Mean Scores, and p-values. 
 
Results: Helland et al (2003) found significant cognitive differences between 4 year old 
children born to DHA and non-DHA supplemented mothers, via MPC scores on the K-
ABC test (106.4[7.4] v. 102.3[11.3]; P=0.049). Helland (2001) and Campoy (2011), 
however, did not note any significant differences between children on either the Fagan 
((55.2[4.5] vs. 55.4[3.7]% at 6 months and 55.5[3.8] vs. 56.2[3.5]% at 9 months) or K-
ABC tests (110[11] vs. 110[14.5] at 6.5 years old) respectively.  
 
Conclusion: Conflicting results from these three RCTs demonstrate that the effects of 
supplementing pregnant and breast-feeding mothers with N-3 fatty acids containing DHA 
on child cognition is inconclusive.   
 
Key Words: DHA supplementation, Pregnancy, Lactation, Cognition. 
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INTRODUCTION 
 
 Cognition is a multi-faceted entity formed from various contributing factors, but, 
in recent years, the role of Docosahexaenoic acid (DHA) in the developing brain has 
become a primary focus. Cognition has often been defined as an avenue for the 
processing of information and application of acquired knowledge, encompassing aspects 
such as awareness, understanding, learning, perception, reasoning, and judgment. 1,2 In 
short, it is an observable outward expression of intelligence. Evidence of this correlation 
is seen in both psychometric evidence and brain-imaging studies. “Factor-analytic studies 
have demonstrated that measures of working memory (cognition) correlate extremely 
highly (r’s >0.90) with the general intelligence factor.” 2 Furthermore, structural MRI’s 
have shown similar activations of the pre-frontal cortex and anterior cingulate gyrus 
when individuals are taking intelligence exams, such as the Raven’s Progressive Matrices 
Test, and during working memory tasks. 2 This paper will evaluate three randomized 
controlled trials (RCTs) that sought to compare the cognition of children born to mothers 
who did and did not take DHA supplementation throughout pregnancy and breastfeeding 
via various intelligence testing. 
 The relevance of cognition to both patients and healthcare providers alike is 
profound. Unlike disease states, which burden varying degrees of the population, 
cognition is a part of every individual’s life.  In a world that emphasizes the importance 
of health, achievement, and success, the possibility of providing one’s unborn child with 
an edge in this arena, through the use of prenatal supplementation, will most certainly 
bring this issue to nearly every health care provider’s door.  It is estimated that up to 95 
percent of pregnant mothers take some type of prenatal supplement. On average, the cost 
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of taking the recommended supplementations of vitamins A through E, folic acid, iron, 
and calcium from three months before pregnancy through a year of breastfeeding totals 
nearly $220 per individual.3,4,5  Furthermore, a great number of healthcare visits 
accompany the birth process in order to assess fetal development and well being. 
Pregnant women are advised to see their obstetrician once each month for weeks 4 
through 28, then twice a month for weeks 28 through 36, and weekly from weeks 36 to 
birth.6  
 Cognition is a complex entity with both genetic and environmental components. 
Fetal brain development undergoes its most rapid period of growth from the third 
trimester through the second year of life. 7 During this critical time, neurologic 
development is heavily dependent on the energy it derives from the mother’s diet via 
placental transfer and breast milk; long-chain polyunsaturated fatty acids play a 
particularly important role. More specifically, it is the N-3 fatty acid, DHA, which makes 
up nearly 30% of brain structure and aids in neuronal cell formation and signaling in the 
gray matter of the cerebral cortex. 7 DHA also plays a role in the ongoing structure of the 
adult brain, where it serves as the most abundant fatty acid in cell membranes, altering 
permeability and enhancing protein activity. 7 “Pregnant and lactating women require at 
least 300mg of daily DHA intake to promote optimal nervous system development in 
their children.”7 By measuring DHA levels in the umbilical artery and vein of infants at 
birth, researchers have correlated low concentration levels to neurologic abnormalities 
and even stillbirths.8  
 Cognitive disparities from child to child have prompted the development of 
various interventional techniques, such as early brain training programs, remediation 
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techniques, and compensatory strategies, to narrow the gap. These strategies, however, 
have proven to be of limited value.9 Due to its relative safety, efficacy, tolerability, and 
known role in neurologic development, DHA supplementation is now being proposed as 
an alternative treatment resource. 
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not the 
supplementation of N-3 fatty acids containing DHA throughout pregnancy and 
breastfeeding improves child cognition. 
METHODS 
 Three double blind randomized controlled studies were used in this review. Each 
study’s population followed a group of women from pregnancy through lactation, as the 
intervention of N-3 fatty acids containing DHA were introduced to the experimental 
groups. The specific concentration and source of DHA intake varied across the studies, as 
did the structure of each control group; the commonality, however, was the absence of 
DHA in whichever prenatal supplement the comparison control group was instructed to 
take. After birth, the transfer of DHA from mother to fetus was confirmed by obtaining 
levels in either blood, the umbilical cord of infants, or maternal milk. Cognitive function 
was then later assessed using various tests, including the Fagan and Kaufman Assessment 
Battery for Children (K-ABC).  
 Key words used in the search included DHA, pregnancy, breastfeeding, and 
cognition. The chosen articles were all written in English and published in peer-reviewed 
journals between 2003 and 2011. Each was found through the PubMed and Medline 
databases, and selected based on its relevance to my initial clinical question and its ability 
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to be correlated to the outcome in question.  The inclusion criteria consisted of 
randomized controlled trials and a population of healthy pregnant women with 
uncomplicated singleton pregnancies. Pregnant women who had previously taken any 
prenatal supplements before the start of the trial were excluded, as were infants suffering 
from premature births, infections, asphyxia, and congenital abnormalities. Summary 
statistics were reported using standard deviations, means, medians, and p-values.    
Table 1: Demographics & Characteristics of Included Studies 
Study Type #Pts Age 
(yrs) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Campoy 
et al10 
(2011) 
Double 
Blind, 
RCT 
270 18-
40 
Healthy 
women, 
Uncomplicated 
Singleton 
Pregnancies, 
weight: 50-92 
kg, intention to 
breast feed 
No prior 
supplementation 
during 
pregnancy, 
premature 
births, 
infections, 
asphyxia, 
congenital 
anomalies 
109 N-3 long chain 
poly unsaturated 
fatty acids 
containing 
500mg/d DHA 
and 0.5% formula 
DHA (from the 
20th wk of 
pregnancy until 
birth and from 
birth until 6 mo 
after delivery, 
respectively) 
Helland 
et al11  
(2001) 
Double 
Blind, 
RCT 
590 19-
35  
Healthy, nulli 
or primi 
parous women, 
singleton 
pregnancies, 
intention to 
breast feed  
No prior 
supplementation 
during 
pregnancy, 
premature 
births, 
infections, 
asphyxia, 
congenital 
anomalies 
245 Cod liver oil with 
DHA 
(1183mg/10mL/d) 
from the 17th wk 
of pregnancy until 
3 mo after 
delivery 
Helland 
et al12 
(2003) 
Double 
Blind, 
RCT 
590 19-
35  
Healthy, nulli 
or primi 
parous women, 
singleton 
pregnancies, 
intention to 
breast feed 
No prior 
supplementation 
during 
pregnancy, 
premature 
births, 
infections, 
asphyxia, 
congenital 
anomalies 
506 Cod liver oil with 
DHA 
(1183mg/10mL/d) 
from the 17th wk 
of pregnancy until 
3 mo after 
delivery 
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OUTCOMES MEASURED 
Each child, whose mother successfully adhered to all experimental procedures, 
was invited to complete either the Fagan or K-ABC test at various ages post-birth.  These 
tests successfully measure cognition by evaluating a child’s ability to process information 
and correlating it to a quantitative exam score.13 In the Fagan Test, this processing is 
measured on the theory that an infant tends to “look longer at new targets, such as a 
picture of a woman’s face, than at one previously seen.” 13 An infant’s “preference for 
novelty” tells us that the infant has the ability to acquire knowledge, process stimuli, and 
make discriminations. 13 A specific computer program then derives novelty scores, which 
are simply “the amount of fixation devoted to the novel picture divided by the total 
fixation time to both the novel and familiar picture, multiplied by 100.” 13 Individual 
novelty preference scores are then compared to the mean, where higher scores indicate 
higher levels of cognitive function.  
The K-ABC test, which is comprised of four scores from sixteen subtests, 
including sequential processing, simultaneous processing, achievement, and mental 
processing scales, was also used to assess cognition.14 “The sequential processing scale 
measures short-term memory and problem solving skills, such as recalling numbers and 
arranging items. The simultaneous processing scale examines skills that require a child to 
process several stimuli at once, such as facial recognition. These two scores comprise the 
mental processing composite (MPC), which is a global measurement of the child’s 
cognitive ability. Finally, the achievement scale focuses on applied skills and facts, such 
as naming famous people and solving riddles.” 14 Standard K-ABC scores have a mean 
score of 100 and a standard deviation of 15 and individual scores are compared to these 
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values accordingly.14 Both the Fagan and K-ABC tests have known efficacy and are 
widely recognized. 
RESULTS 
 Three double blind randomized controlled trials compared the cognitive function 
of infants born to mothers supplemented with varying levels of DHA throughout 
pregnancy and breastfeeding to cognitive levels of children born to mothers whose 
controlled supplements contained no DHA. Helland’s (2001 and 2003) control group 
received corn oil and assessed child cognition at 6 and 9 months and 4 years of age 
respectively, while Campoy et al’s control group received a placebo and assessed child 
cognition at 6.5 years of age. The inclusion and exclusion criteria of all three studies were 
similar (Table 1). All enrolled mothers were young, healthy, adults whose 
supplementation began in the second trimester and continued through, at least, 3 months 
of breastfeeding. Premature infants and multiple gestations were excluded because they 
are more vulnerable to DHA deficiencies, as they have less time or opportunity to draw 
on stores from the mom. 10,11,12 
Data from all trials were reported as continuous data and could not be converted 
into a dichotomous format; therefore, calculations evaluating tolerability, adverse events, 
and treatment effects could not be computed. Participants in all three studies did however 
receive written information and consented to participate in each trial, all of which were 
approved by regional ethics committees. The women were also free to withdraw without 
giving a reason, however, 43.1% and 38.7% of participants in the cod liver and corn oil 
groups, respectively, from the Helland studies withdrew because of “feelings of 
discomfort” the supplements gave them,11,12 and Campoy et al stated that “no illness or 
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disability interfering with normal neurologic development was observed amongst its 
participants.”10  
Across all studies, participants also submitted pregnancy records, food frequency 
questionnaires, birth records, and blood and milk sampling. No significant variations in 
dietary intake, maternal age, smoking, or parental education levels existed.10,11,12 
Maternal blood or milk sampling was used to evaluate the transfer of DHA from mother 
to fetus and confirm higher levels in the experimental groups. 10,11,12 All trials 
demonstrated this transfer, hence the validity of separating the groups into a experimental 
and control population was confirmed.   
 In Helland et al (2001) 590 pregnant Norwegian mothers were recruited from the 
National Hospital and Baerum Central Hospital in Oslo between December 1994 and 
October 1996.11 They were randomized into both a control and experimental group by a 
computer program and instructed to take 10mL/day of either cod liver oil (containing 
DHA) or corn oil.  The lack of compliance was 9.5% in the cod liver oil group and 16.1% 
in the corn oil group.11 115 controls and 130 women receiving DHA completed the 
intervention through the third month after delivery and allowed the cognitive Fagan test 
to be performed on their children at both 6 and 9 months of age.11  
In this particular version of the exam, the infants received the same 10 novelty 
problems on both occasions; all problems involved comparison of familiar and new 
digitized faces on a computer monitor.11 Scores were computed as above described in the 
methods section; A 2-tailed student t-test was used to examine differences between the 
control and experimental groups, based on mean scores and standard deviations; a p value 
of <0.05 was considered significant. 11 “No significant differences in novelty preference 
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between the cod and corn oil groups at either 6 or 9 months of age were found” (55.2[4.5] 
vs. 55.4[3.7]% and 55.5[3.8] vs. 56.2[3.5]% respectively). 11 
Table 2: Treatment v. Control Fagan Test Data at 6 and 9 months of age, Mean[SD] 
 6 months 9 months 
Children born to mother’s 
supplemented with cod liver 
oil containing DHA 
(N=130) 
55.2[4.5] 56.2[3.5] 
Children born to mother’s 
supplemented with corn oil 
lacking DHA (N=115) 
55.4[3.7] 56.2[3.5] 
 
In Helland et al (2003), the same children, born to mothers in the very population 
above described, were followed up with at 4 years of age. 48 children born to mothers 
who had taken cod liver oil and 36 children born to mothers who had taken corn oil 
participated in cognition assessment via the K-ABC test. “In a backward stepwise 
regression model with Mental Processing Composite as the dependent variable, maternal 
intake of DHA was found to be an independent variable of clinical significance” 
(r2=0.07; P=0.03).12  T-tests then measured differences between continuous variables, 
and p values <0.05 were considered significant. Children in the cod liver oil group had 
significantly higher MPC scores than the children in the corn oil group (106.4[7.4] v. 
102.3[11.3]; P=0.049). 12  
Table 3: Treatment v. Control MPC Scores at 4 Years of Age, Mean[SD] 
 MPC Scores from K-ABC Test 
Children born to mother’s 
supplemented with cod liver oil 
containing DHA (N=48) 
106.4[7.4] 
Children born to mother’s 
supplemented with corn oil lacking 
DHA (N=36) 
102.3[11.3] 
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Campoy et al (2011) recruited healthy pregnant women, at less then 20 weeks of 
gestation, from three different European antenatal care clinics. “Blockwise 
randomization” was performed at each center and the women were separated into four 
groups.10 For the purpose of this analysis, however, we will focus only on the groups of 
women who received either supplements containing only 500 mg of DHA or a placebo 
from pregnancy through 6 months of breastfeeding. Infants born to DHA supplemented 
mothers who could no longer breastfeed were still allowed to remain in the study and 
received either a formula containing 0.5% DHA until 6 months of age or a formula 
lacking DHA.10 37 children from the DHA supplemented group and 45 children from the 
control group complied with the experiment and took the K-ABC test at 6.5 years of 
age.10 No compliance percentages from the mother’s were reported.  The Kruskal-Walllis 
test was performed to assess the effects of supplementation based on median values and 
ranges obtained from K-ABC scores; p values <0.05 were considered significant. No 
significant differences in the MPC scores on the K-ABC test were found between the 
DHA supplemented and placebo groups (110[11] vs. 110[14.5] respectively). 10  
Table 4: Treatment v. Control MPC Scores at 6.5 years of Age, Median[Range] 
 MPC Scores from K-ABC Test 
Children born to mother’s 
supplemented with cod liver oil 
containing DHA (N=37) 
110[11] 
Children born to mother’s 
supplemented with a placebo (N=45) 
110[14.5] 
 
DISCUSSION 
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Using three double blind RCT’s, this meta-analysis reviewed the affects of DHA 
supplementation, to pregnant and breastfeeding mothers, on the cognition of their yet 
unborn children. Each article selected healthy mothers whose children were not at any 
predetermined risk for cognitive deficits, however, recent studies have suggested running 
similar experiments in at risk children. The validity and blinding of each RCT was 
without error, however drop out rates were high, as follow up required years of 
compliance, leaving the sample sizes relatively small. Furthermore, child cognition was 
only assessed using two exams and many other options for evaluation exist.  
DHA is a relatively safe supplement when used as directed (amounts under 3 
grams per day). Its supplementation is contraindicated in patients taking blood pressure 
and anticoagulant medications as it may cause pressure to drop too low and also slows 
clotting.15 Under the Dietary Supplement Health and Education Act of 1994, the Food 
and Drug Administration regulates DHA by requiring its manufacturers to ensure its 
safety before marking and intervenes if any harmful product does reach stores.16 Since 
the start of its widespread use, only minimal adverse affects, such as nausea, intestinal 
gas, and bruising, have been noted. 15 No black box warnings exist. Insurances do not 
cover DHA supplements yet its availability and use is widespread.  
DHA supplementation has, for example, begun to be implemented in the 
treatment of various disease states. In the Rotterdam studies, researches noted protective 
and reductive effects of DHA on the incidence of Alzheimer’s; DHA has even been 
shown to improve age related memory loss. 7 Another study measured the impact of DHA 
on visual development in infants. Those who received DHA-enriched egg yolks had 
greatly enhanced retina and visual cortex maturation. 7   Other less common uses include 
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the treatment of Coronary Artery Disease, ADHD, and, when given along with EPA, 
Psoriasis.7  
CONCLUSION 
The supplementation of N-3 fatty acids containing DHA, to pregnant and breast 
feeding mothers, has shown inconclusive affects on child cognition. Helland et al (2003) 
was the only RCT that detected a significant difference in cognitive scores between 
experimental and control groups. Noting that this is the same population a previous trial 
tested (at an earlier age using a different cognitive assessment) with insignificant results, 
DHA supplementation’s effects remain conflicting at best.  
The administration of DHA in all studies relied solely on the mother’s compliance 
and honest reporting of intake.  In the future, the reliability of such intake should be 
standardized and controlled.  The known correlation between DHA and brain structure 
warrants future investigation on this matter. Continuing research should consider 
enhancing the dose of DHA supplementation, testing children at later stages of life, and 
even implementing new tests to assess cognition, as this matter will continue to be of 
great importance in the coming years. 
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